Bayer AG

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

38.20%

Market Cap

33.92 Bil.

P/E Ratio

0.00

Dividend Yield

0.30 %

Earnings per Share

-3.68 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE35.4 G0 Units
PRICE DETERMINATION TIME06/04/2026 / 09:55:34 PM
DAILY VOLUME (UNITS)10,801
DAILY HIGH / LOW35.6234.55
PREV. DAY'S PRICE34.53 (06/03)
CHANGE DAY BEFORE
+0.87
2.52 %
52 WEEK HIGH / LOW49.89 (02/17)24.82 (08/06)
More Price Information

Key Figures (in EUR)

2027e2026e202520242023
EARNINGS PER SHARE4.634.38-3.68-2.60-2.99
DIVIDENDS PER SHARE0.110.110.110.110.11
DIVIDEND YIELD IN %--0.30 %0.57 %0.33 %
DIVIDEND GROWTH IN %--0.00 %0.00 %-95.42 %
PRICE - EARNINGS RATIO7.898.347.54(e)--
PRICE - BOOK RATIO--1.400.591.00
PRICE - SALES RATIO--0.800.410.69
PRICE - CASH FLOW RATIO--7.953.228.13
Further Key Figures

Master Data

WKN
BAY001
ISIN
DE000BAY0017
SYMBOL
BAYN
EXCHANGE SEGMENT
Regulierter Markt
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Bayer
INDEX MEMBERSHIP
DAX
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
982.42 Mil.
MARKET CAPITALISATION
33.92 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-9.11 %
-8.99 %
-8.41 %
0.74 %
38.20 %
-34.57 %
-33.90 %
-6.64 %
HIGH38.0139.5641.7749.8949.8953.8067.9649.89
LOW32.9632.9632.9632.9624.8218.4318.4332.96
Dividend
per share

Company profile

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

(in 1 days)
06/05/26European Renal Association Congress
(in 1 days)
06/05/26European Renal Association Congress
(in 1 days)
06/05/26European Renal Association Congress
(in 61 days)
08/04/26Q2 2026 Earnings Release
(in 90 days)
09/02/26Analyst Meeting - Crop Science